A healthcare company trying to launch a new headache curing drug. Should or shouldn't they invest when they already have a general painkiller in the market
Back to overview
18
How would I approach this? Possible Framework?
2
4.4k
Be the first to answer!
Nobody has responded to this question yet.
Top answer
Vlad
edited on Jun 05, 2018
Coach
McKinsey / Accenture Alum / Got all BIG3 offers / Harvard Business School
Hi,
Hi,
I recommend starting with clarifying the objective - Which metrics you need to achieve with the product? Most probably it will be ROI.
I would also clarify whether it's our painkiller on the market or the product of the competitors since competition and cannibalization are the two different cases. Then I will follow up with the structure:
Analyze our product:
- The value proposition of a product compared to the painkiller
- Different use cases of a product compared to the painkiller
- Unit economics (Current unit costs and costs in relation to scale, Investments, ROI targets, Competitor / substitutes pricing)
- Key capabilities to compete (Patent, distribution, etc)
Analyze the market:
- Size and growth rates of the painkiller market
- Size and growth rate of headache drugs
- Regulation - are they both OTC? Prescribed? Is it different by geography?
Analyze the competitors:
- Market shares, growth rates, profits
- Product (Value proposition)
- Unit economics (Value proposition vs. price vs. costs)
- Key capabilities (Distribution, supply, assets, knowledge, etc)
investment decision:
- Costs, benefits, and investments
- ROI
- Risks
Best!
0 comments
Sidi
on Jun 05, 2018
Coach
McKinsey Senior EM & BCG Consultant | Interviewer at McK & BCG for 7 years | Coached 500+ candidates secure MBB offers
Hi Anonymous,
the new drug should be launched if the net value associated with this move exceeds the investment cost over the client's target investment horizon. Morover, Risk needs to be manageable.
So you have 4 buckets to investigate:
- Net value (expected profits of new drug + impact on profits of current painkiller (potential cannibalization!))
- Investment Horizon
- Investment need for launch of the new drug
- Wider risks associated with the new drug (regulation? competitive responses? consumer sentiment?...)
Cheers, Sidi
Similar Questions
Most Popular Posts
Visa sponsorship in MBB SEA
8
on Jan 28, 2026
Global
8
100+
Top answer by
Ashwin
Coach
Bain Senior Manager | 500+ MBB Offers
8 Answers
100+ Views
+5
After McKinsey solve game assessment?
9
on Jan 29, 2026
Middle East
7
200+
Top answer by
Evelina
Coach
Lead coach for Revolut Problem Solving and Bar Raiser l EY-Parthenon l BCG
7 Answers
200+ Views
+4
Mckinsey's way of shortlisting candidates?
12
on Jan 30, 2026
Middle East
7
100+
Top answer by
Alessandro
Coach
McKinsey Senior Engagement Manager | Interviewer Lead | 1,000+ real MBB interviews | 2026 Solve, PEI, AI-case specialist
7 Answers
100+ Views
+4
BCG Bob Camp video interview
18
on Jan 30, 2026
DACH
6
200+
Top answer by
Ashwin
Coach
Bain Senior Manager | 500+ MBB Offers
6 Answers
200+ Views
+3
HR part in McKinsey
9
on Jan 31, 2026
Middle East
8
100+
Top answer by
Alessandro
Coach
McKinsey Senior Engagement Manager | Interviewer Lead | 1,000+ real MBB interviews | 2026 Solve, PEI, AI-case specialist
8 Answers
100+ Views
+5